Image guided therapy: The advent of theranostic agents
Theranostic agents represent a recently introduced class of imaging probes designed to offer to pharmacologists and physicians a robust tool for minimally invasive in vivo visualization of drug delivery/release and therapy monitoring. By means of these agents, novel strategies able to integrate diag...
Gespeichert in:
| Veröffentlicht in: | Journal of controlled release 2012-07, Vol.161 (2), p.328-337 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 337 |
|---|---|
| container_issue | 2 |
| container_start_page | 328 |
| container_title | Journal of controlled release |
| container_volume | 161 |
| creator | Terreno, Enzo Uggeri, Fulvio Aime, Silvio |
| description | Theranostic agents represent a recently introduced class of imaging probes designed to offer to pharmacologists and physicians a robust tool for minimally invasive in vivo visualization of drug delivery/release and therapy monitoring.
By means of these agents, novel strategies able to integrate diagnosis and therapy could be developed. This highly interdisciplinary research field is one of the more innovative products resulting from the synergism between molecular imaging and nanomedicine. Potential applications of theranosis include the in vivo assessment of drug biodistribution and accumulation at the target site, visualization of the drug release from a given nanocarrier, and real-time monitoring of the therapeutic outcome. The expected end-point of theranostic agents is to provide a fundamental support for the optimization of innovative diagnostic and therapeutic strategies that could contribute to emerging concepts in the field of the “personalized medicine”.
This perspective paper aims at providing the reader the basic principles of theranosis with a particular emphasis to the design of theranostic agents.
[Display omitted] |
| doi_str_mv | 10.1016/j.jconrel.2012.05.028 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1034813416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016836591200435X</els_id><sourcerecordid>1034813416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-757302c7fbb9abc2d0d44ed0d0000fff8b48e601d90d58f34212ede7a7b76fd33</originalsourceid><addsrcrecordid>eNqNkE1P3DAQhq2Kqizb_gRojlySjr8TLgihliIh9VA4W449XrzaTbZ2Fol_j1fZ9kovM9LomZlXDyHnFBoKVH1bN2s3Dgk3DQPKGpANsPYDWdBW81p0nTwhi8K1NVeyOyVnOa8BQHKhP5FTxhRTnYAFUfdbu8JqtY8efTU9Y7K716vq8Rkr619wmKoxzONhzFN0VaGHKX8mH4PdZPxy7Evy9OP74-3P-uHX3f3tzUPtBGNTraXmwJwOfd_Z3jEPXggstUSBEELbixYVUN-Bl23gglGGHrXVvVbBc74kl_PdXRr_7DFPZhuzw83GDjjus6HARUu5oOo_UEYpU1QcUDmjLo05Jwxml-LWptcCmYNdszZHu-Zg14A0xW7Zuzi-2Pdb9P-2_uoswNcZCHY0dpViNk-_ywUJQLU62FiS65nAYu0lYjLZRRwc-pjQTcaP8Z0Qb9kmlbI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1021126146</pqid></control><display><type>article</type><title>Image guided therapy: The advent of theranostic agents</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Terreno, Enzo ; Uggeri, Fulvio ; Aime, Silvio</creator><creatorcontrib>Terreno, Enzo ; Uggeri, Fulvio ; Aime, Silvio</creatorcontrib><description>Theranostic agents represent a recently introduced class of imaging probes designed to offer to pharmacologists and physicians a robust tool for minimally invasive in vivo visualization of drug delivery/release and therapy monitoring.
By means of these agents, novel strategies able to integrate diagnosis and therapy could be developed. This highly interdisciplinary research field is one of the more innovative products resulting from the synergism between molecular imaging and nanomedicine. Potential applications of theranosis include the in vivo assessment of drug biodistribution and accumulation at the target site, visualization of the drug release from a given nanocarrier, and real-time monitoring of the therapeutic outcome. The expected end-point of theranostic agents is to provide a fundamental support for the optimization of innovative diagnostic and therapeutic strategies that could contribute to emerging concepts in the field of the “personalized medicine”.
This perspective paper aims at providing the reader the basic principles of theranosis with a particular emphasis to the design of theranostic agents.
[Display omitted]</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2012.05.028</identifier><identifier>PMID: 22626940</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Controlled release ; Diagnostic Imaging ; Drug delivery ; Drug delivery and release ; Drug Delivery Systems ; Drug Monitoring ; drugs ; Humans ; image analysis ; Image-guided therapies ; imaging ; In vivo imaging ; interdisciplinary research ; monitoring ; nanocarriers ; Nanomedicine ; Nanomedicine - methods ; Nanoparticles - therapeutic use ; physicians ; Probes ; synergism</subject><ispartof>Journal of controlled release, 2012-07, Vol.161 (2), p.328-337</ispartof><rights>2012 Elsevier B.V.</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-757302c7fbb9abc2d0d44ed0d0000fff8b48e601d90d58f34212ede7a7b76fd33</citedby><cites>FETCH-LOGICAL-c422t-757302c7fbb9abc2d0d44ed0d0000fff8b48e601d90d58f34212ede7a7b76fd33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jconrel.2012.05.028$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22626940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Terreno, Enzo</creatorcontrib><creatorcontrib>Uggeri, Fulvio</creatorcontrib><creatorcontrib>Aime, Silvio</creatorcontrib><title>Image guided therapy: The advent of theranostic agents</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>Theranostic agents represent a recently introduced class of imaging probes designed to offer to pharmacologists and physicians a robust tool for minimally invasive in vivo visualization of drug delivery/release and therapy monitoring.
By means of these agents, novel strategies able to integrate diagnosis and therapy could be developed. This highly interdisciplinary research field is one of the more innovative products resulting from the synergism between molecular imaging and nanomedicine. Potential applications of theranosis include the in vivo assessment of drug biodistribution and accumulation at the target site, visualization of the drug release from a given nanocarrier, and real-time monitoring of the therapeutic outcome. The expected end-point of theranostic agents is to provide a fundamental support for the optimization of innovative diagnostic and therapeutic strategies that could contribute to emerging concepts in the field of the “personalized medicine”.
This perspective paper aims at providing the reader the basic principles of theranosis with a particular emphasis to the design of theranostic agents.
[Display omitted]</description><subject>Animals</subject><subject>Controlled release</subject><subject>Diagnostic Imaging</subject><subject>Drug delivery</subject><subject>Drug delivery and release</subject><subject>Drug Delivery Systems</subject><subject>Drug Monitoring</subject><subject>drugs</subject><subject>Humans</subject><subject>image analysis</subject><subject>Image-guided therapies</subject><subject>imaging</subject><subject>In vivo imaging</subject><subject>interdisciplinary research</subject><subject>monitoring</subject><subject>nanocarriers</subject><subject>Nanomedicine</subject><subject>Nanomedicine - methods</subject><subject>Nanoparticles - therapeutic use</subject><subject>physicians</subject><subject>Probes</subject><subject>synergism</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1P3DAQhq2Kqizb_gRojlySjr8TLgihliIh9VA4W449XrzaTbZ2Fol_j1fZ9kovM9LomZlXDyHnFBoKVH1bN2s3Dgk3DQPKGpANsPYDWdBW81p0nTwhi8K1NVeyOyVnOa8BQHKhP5FTxhRTnYAFUfdbu8JqtY8efTU9Y7K716vq8Rkr619wmKoxzONhzFN0VaGHKX8mH4PdZPxy7Evy9OP74-3P-uHX3f3tzUPtBGNTraXmwJwOfd_Z3jEPXggstUSBEELbixYVUN-Bl23gglGGHrXVvVbBc74kl_PdXRr_7DFPZhuzw83GDjjus6HARUu5oOo_UEYpU1QcUDmjLo05Jwxml-LWptcCmYNdszZHu-Zg14A0xW7Zuzi-2Pdb9P-2_uoswNcZCHY0dpViNk-_ywUJQLU62FiS65nAYu0lYjLZRRwc-pjQTcaP8Z0Qb9kmlbI</recordid><startdate>20120720</startdate><enddate>20120720</enddate><creator>Terreno, Enzo</creator><creator>Uggeri, Fulvio</creator><creator>Aime, Silvio</creator><general>Elsevier B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20120720</creationdate><title>Image guided therapy: The advent of theranostic agents</title><author>Terreno, Enzo ; Uggeri, Fulvio ; Aime, Silvio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-757302c7fbb9abc2d0d44ed0d0000fff8b48e601d90d58f34212ede7a7b76fd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Controlled release</topic><topic>Diagnostic Imaging</topic><topic>Drug delivery</topic><topic>Drug delivery and release</topic><topic>Drug Delivery Systems</topic><topic>Drug Monitoring</topic><topic>drugs</topic><topic>Humans</topic><topic>image analysis</topic><topic>Image-guided therapies</topic><topic>imaging</topic><topic>In vivo imaging</topic><topic>interdisciplinary research</topic><topic>monitoring</topic><topic>nanocarriers</topic><topic>Nanomedicine</topic><topic>Nanomedicine - methods</topic><topic>Nanoparticles - therapeutic use</topic><topic>physicians</topic><topic>Probes</topic><topic>synergism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Terreno, Enzo</creatorcontrib><creatorcontrib>Uggeri, Fulvio</creatorcontrib><creatorcontrib>Aime, Silvio</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Terreno, Enzo</au><au>Uggeri, Fulvio</au><au>Aime, Silvio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Image guided therapy: The advent of theranostic agents</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2012-07-20</date><risdate>2012</risdate><volume>161</volume><issue>2</issue><spage>328</spage><epage>337</epage><pages>328-337</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><abstract>Theranostic agents represent a recently introduced class of imaging probes designed to offer to pharmacologists and physicians a robust tool for minimally invasive in vivo visualization of drug delivery/release and therapy monitoring.
By means of these agents, novel strategies able to integrate diagnosis and therapy could be developed. This highly interdisciplinary research field is one of the more innovative products resulting from the synergism between molecular imaging and nanomedicine. Potential applications of theranosis include the in vivo assessment of drug biodistribution and accumulation at the target site, visualization of the drug release from a given nanocarrier, and real-time monitoring of the therapeutic outcome. The expected end-point of theranostic agents is to provide a fundamental support for the optimization of innovative diagnostic and therapeutic strategies that could contribute to emerging concepts in the field of the “personalized medicine”.
This perspective paper aims at providing the reader the basic principles of theranosis with a particular emphasis to the design of theranostic agents.
[Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>22626940</pmid><doi>10.1016/j.jconrel.2012.05.028</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0168-3659 |
| ispartof | Journal of controlled release, 2012-07, Vol.161 (2), p.328-337 |
| issn | 0168-3659 1873-4995 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1034813416 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Animals Controlled release Diagnostic Imaging Drug delivery Drug delivery and release Drug Delivery Systems Drug Monitoring drugs Humans image analysis Image-guided therapies imaging In vivo imaging interdisciplinary research monitoring nanocarriers Nanomedicine Nanomedicine - methods Nanoparticles - therapeutic use physicians Probes synergism |
| title | Image guided therapy: The advent of theranostic agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T07%3A59%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Image%20guided%20therapy:%20The%20advent%20of%20theranostic%20agents&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Terreno,%20Enzo&rft.date=2012-07-20&rft.volume=161&rft.issue=2&rft.spage=328&rft.epage=337&rft.pages=328-337&rft.issn=0168-3659&rft.eissn=1873-4995&rft_id=info:doi/10.1016/j.jconrel.2012.05.028&rft_dat=%3Cproquest_cross%3E1034813416%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1021126146&rft_id=info:pmid/22626940&rft_els_id=S016836591200435X&rfr_iscdi=true |